newsroompost
  • youtube
  • facebook
  • twitter

PM Modi reviews Covid-19 and Vaccination situation with top officials

PM Modi stressed that there is no substitute to testing, tracking and treatment. Early testing and proper tracking remains key to reduce mortality. He also said that local administrations need to be proactive and sensitive to people’s concerns.

New Delhi: Amid the record surge in COVID-19 cases across the country, Prime Minister Narendra Modi on Saturday held a meeting to review the coronavirus pandemic and vaccination situation.

PM Modi chaired a meeting to review the status of preparedness to handle ongoing Covid-19 pandemic. Various aspects relating to medicines, oxygen, ventilators and vaccination were discussed.

The Prime Minister said that together India had defeated Covid last year & India can do it again, with the same principles but faster speed and coordination.

PM Modi stressed that there is no substitute to testing, tracking and treatment. Early testing and proper tracking remains key to reduce mortality. He also said that local administrations need to be proactive and sensitive to people’s concerns.

The Prime Minister directed that close coordination with States must be ensured in handling the pandemic. He said that all necessary measures must be taken to ramp up the availability of hospital beds for Covid patients. The Prime Minister also directed that additional supply of beds through temporary hospitals and isolation centres should be ensured.

PM reviews supply status of Remdesivir

Remdesivir, Covid-19 treatment drug to be launched in India at Rs 4,800/- per vial

PM spoke about the need to utilize the full potential of India’s pharmaceutical industry to meet the rising demand of various medicines. He reviewed the status of supply of Remdesivir and other medicines. The Prime Minister was briefed on actions taken to address the issue of availability of Remdesivir. Through the efforts of the Government, capacity and production augmentation for manufacturing of Remdesivir has been ramped up to provide around 74.10 lakh vials/month in May while the normal production output in January-February being just 27-29 lakh vials/month. Supplies have also increased from 67,900 vials on 11th April going up to over 2,06,000 vials on 15th April 2021 which are being particularly focused on states with high caseload and high demand. He took note of the ramped up production capacity, and directed that issues relating to real-time supply chain management to States must be resolved urgently in coordination with the States.

The Prime Minister directed that use of Remdesivir and other medicines must be in accordance with approved medical guidelines, and that their misuse and black marketing must be strictly curbed.

PM directs speedy installation of medical oxygen plants

On the issue of supply of medical oxygen, the Prime Minister directed that the installation of approved medical oxygen plants should be sped up. 162 PSA Oxygen plants are being installed in 32 States/UTs from PM CARES. The officers informed that 1 lakh cylinders are being procured & they will be supplied to states soon.

There is no shortage of oxygen, producing over 6,900 metric tonne oxygen: Health Ministry

The officers briefed the PM that they are in constant supply with 12 high burden states in assessing the current and future requirement of medical oxygen. A supply mapping plan for 12 high burden states till 30th April has also been undertaken.

The Prime Minister also said that supply of oxygen required for production of medicines and equipment necessary to handle the pandemic should also be ensured.

‘Exhaust all resources, ramp up vaccine production’

The Prime Minister also reviewed the status of availability & supply of ventilators. The Prime Minister noted that a real time monitoring system has been created, and directed that concerned State governments should be sensitized to use the system proactively.

pm modi

On the issue of vaccination, the Prime Minister directed all officials to make efforts to utilize the entire national capacity, in public as well as private sector, to ramp up vaccine production.